Panagora Asset Management’s Fulgent Genetics FLGT Stock Holding History

Panagora Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,988	Closed	-$499K	–	1199
2025 Q4	$499K	Hold	18,988	–	–	﹤0.01%	875
2025 Q3	$429K	Hold	18,988	–	–	﹤0.01%	843
2025 Q2	$377K	Sell	18,988 -1,833	-9%	-$35.7K	﹤0.01%	874
2025 Q1	$352K	Sell	20,821 -7,459	-26%	-$127K	﹤0.01%	898
2024 Q4	$522K	Sell	28,280 -21	-0.1%	-$410	﹤0.01%	825
2024 Q3	$615K	Buy	+28,301	New	+$633K	﹤0.01%	869
2021 Q2	–	Sell	-155	Closed	-$15K	–	2837
2021 Q1	$15K	Hold	155	–	–	﹤0.01%	2345
2020 Q4	$8K	Sell	155 -260	-63%	-$10.9K	﹤0.01%	2337
2020 Q3	$17K	Hold	415	–	–	﹤0.01%	2243
2020 Q2	$7K	Hold	415	–	–	﹤0.01%	2287
2020 Q1	$4K	Hold	415	–	–	﹤0.01%	2296
2019 Q4	$5K	Hold	415	–	–	﹤0.01%	2235
2019 Q3	$4K	Buy	+415	New	+$3.94K	﹤0.01%	2312

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Panagora Asset Management's FLGT Position: Q1 2026 in Review

Panagora Asset Management sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 18,988 shares — an estimated $499K sold.

Panagora Asset Management first reported a position in FLGT in Q3 2019 and held it in 13 quarters. The position peaked at $615K in Q3 2024. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

Panagora Asset Management reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
Panagora Asset Management sold 18,988 Fulgent Genetics shares in Q1 2026, an estimated $499K.
Panagora Asset Management first reported a position in Fulgent Genetics in Q3 2019 and held it in 13 quarters.
Panagora Asset Management's Fulgent Genetics position peaked at $615K in Q3 2024.
158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.